RUA Life Sciences plc
RUA.L · LSE
3/31/2025 | 9/30/2024 | 3/31/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£635 | £636 | -£430 | -£1,010 |
| Dep. & Amort. | £243 | £178 | £179 | £185 |
| Deferred Tax | £0 | £0 | -£11 | -£200 |
| Stock-Based Comp. | £61 | £0 | -£96 | £61 |
| Change in WC | -£3 | -£58 | -£549 | £226 |
| Other Non-Cash | £363 | -£975 | £462 | -£166 |
| Operating Cash Flow | £4 | -£219 | -£445 | -£904 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£27 | -£35 | -£13 | -£42 |
| Net Acquisitions | -£106 | £208 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £1 | £0 | -£9 | -£21 |
| Investing Cash Flow | -£132 | £173 | -£22 | -£42 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -£204 | £8 | -£119 | -£30 |
| Stock Issued | £0 | £0 | £3,974 | £0 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £71 | -£71 | £63 | £0 |
| Financing Cash Flow | -£133 | -£63 | £3,918 | -£30 |
| Forex Effect | £24 | -£43 | -£13 | -£15 |
| Net Chg. in Cash | -£212 | -£152 | £3,438 | -£991 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £3,779 | £3,931 | £493 | £1,484 |
| End Cash | £3,567 | £3,779 | £3,931 | £493 |
| Free Cash Flow | -£23 | -£254 | -£458 | -£946 |